The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
Open accessAbstract
Chemokines, small pro-inflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are major regulators of cell trafficking and adhesion. The chemokine CXCL12 (also called stromal-derived factor-1) is an important α-chemokine that binds primarily to its cognate receptor CXCR4 and thus regulates the trafficking of normal and malignant cells. For many years, it was believed that CXCR4 was the only receptor for CXCL12. Yet, recent work has demonstrated that CXCL12 also binds to another seven-transmembrane span receptor called CXCR7. Our group and others have established critical roles for CXCR4 and CXCR7 on mediating tumor metastasis in several types of cancers, in addition to their contributions as biomarkers of tumor behavior as well as potential therapeutic targets. Here, we review the current concepts regarding the role of CXCL12 / CXCR4 / CXCR7 axis activation, which regulates the pattern of tumor growth and metastatic spread to organs expressing high levels of CXCL12 to develop secondary tumors. We also summarize recent therapeutic approaches to target these receptors and/or their ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer
Wang, J., Shiozawa, Y., Wang, J., Wang, Y., Jung, Y., Pienta, K. J., Mehra, R., Loberg, R., & Taichman, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707465200 · Cited by 457
Self-citationRetractedWang, J., Wang, J., Sun, Y., Song, W., Nor, J. E., Wang, C. Y., & Taichman, R. S. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.022 · Cited by 160
Self-citationRetractedA Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer
Wang, J., Wang, J., Dai, J., Jung, Y., Wei, C.-L., Wang, Y., Havens, A. M., Hogg, P. J., Keller, E. T., Pienta, K. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2971 · Cited by 159
Self-citationRetractedInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600 · cited 6×
“As seen in other tumors, hypoxia is able to induce a significant increase in the expression levels of CXCR4 on NSCLC cells through the VHL-HIF-1α pathway, supporting the notion that HIF-1α-mediated upregulation of CXCR4 may be a common response of tumor cells to hypoxia [90, 91].”
BackgroundInfluentialA multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N., et al. (2002) · Nature Immunology · doi:10.1038/ni813 · Cited by 1,332
Self-citationMolecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,263
C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,170
Aiuti, A., Webb, I. J., Bleul, C., Springer, T., & Gutierrez-Ramos, J. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.111 · Cited by 1,158
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Yilmaz, Ö. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature04703 · Cited by 1,113
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
Taichman, R. S., Cooper, C. R., Keller, E. T., Pienta, K. J., Taichman, N. S., & McCauley, L. K. (2002) · PubMed · Cited by 1,108
Self-citationThe Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes
Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y. C., Harriague, J., Moepps, B., Arenzana-Seisdedos, F., Thelen, M., & Bachelerie, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508234200 · Cited by 1,040
Stem Cells and Cancer: Two Faces of Eve
Clarke, M. F., & Fuller, M. (2006) · Cell · doi:10.1016/j.cell.2006.03.011 · Cited by 905
The significance of cancer cell expression of the chemokine receptor CXCR4
Balkwill, F. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 758
Signal Sequence Trap: a Cloning Strategy for Secreted Proteins and Type I Membrane Proteins
Tashiro, K., Tada, H., Heilker, R., Shirozu, M., Nakano, T., & Honjo, T. (1993) · Science · doi:10.1126/science.8342023 · Cited by 713
Guidance of Primordial Germ Cell Migration by the Chemokine SDF-1
Doitsidou, M., Reichman-Fried, M., Stebler, J., Köprunner, M., Dörries, J., Meyer, D., Esguerra, C. V., Leung, T., & Raz, E. (2002) · Cell · doi:10.1016/s0092-8674(02)01135-2 · Cited by 697
Normal Stem Cells and Cancer Stem Cells: The Niche Matters
Li, L., & Neaves, W. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3986 · Cited by 675
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Lazennec, G., & Richmond, A. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.003 · Cited by 650
Sierro, F., Biben, C., Martínez-Muñoz, L., Mellado, M., Ransohoff, R. M., Li, M., Woehl, B., Leung, H., Groom, J., Batten, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702229104 · Cited by 624
Control of Chemokine-Guided Cell Migration by Ligand Sequestration
Boldajipour, B., Mahabaleshwar, H., Kardash, E., Reichman-Fried, M., Blaser, H., Minina, S., Wilson, D., Xu, Q., & Raz, E. (2008) · Cell · doi:10.1016/j.cell.2007.12.034 · Cited by 622
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y., Schmidt, K., Kieran, M. W., Luster, A. D., & Segal, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235846100 · Cited by 615
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F., & Lagane, B. (2009) · Blood · doi:10.1182/blood-2008-12-196618 · Cited by 613
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C. M., Gerard, N. P., Gerard, C., & Lefkowitz, R. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912852107 · Cited by 600
Ponomaryov, T., Peled, A., Petit, I., Taichman, R. S., Habler, L., Sandbank, J., Arenzana-Seisdedos, F., Magerus, A., Caruz, A., Fujii, N., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10329 · Cited by 584
Self-citationMatsunaga, T., Takemoto, N., Sato, T., Takimoto, R., Tanaka, I., Fujimi, A., Akiyama, T., Kuroda, H., Kawano, Y., Kobune, M., et al. (2003) · Nature Medicine · doi:10.1038/nm909 · Cited by 563
Journal of Biological Regulators and Homeostatic Agents
Bolognesi, A. (2006) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · Cited by 548
Miao, Z., Luker, K. E., Summers, B. C., Berahovich, R., Bhojani, M. S., Rehemtulla, A., Kleer, C. G., Essner, J. J., Nasevicius, A., Luker, G. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610444104 · Cited by 533
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 471
Embryonic Expression and Function of the Chemokine SDF-1 and Its Receptor, CXCR4
McGrath, K. E., Koniski, A. D., Maltby, K. M., McGann, J. K., & Palis, J. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9405 · Cited by 466
Rønnov-Jessen, L., Petersen, O. W., Koteliansky, V. E., & Bissell, M. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117736 · Cited by 444
Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo
Sun, Y., Wang, J., Shelburne, C. E., Lopatin, D. E., Chinnaiyan, A. M., Rubin, M. A., Pienta, K. J., & Taichman, R. S. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10522 · Cited by 443
Self-citationThe chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
Zeelenberg, I. S., Stalle, L. R.-V., & Roos, E. (2003) · PubMed · Cited by 430
Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., et al. (2000) · PubMed · Cited by 424
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0935fje · Cited by 421
Geminder, H., Sagi-Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I. P., & Ben-Baruch, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4747 · Cited by 409
Mori, T., Doi, R., Koizumi, M., Toyoda, E., Ito, D., Kami, K., Masui, T., Fujimoto, K., Tamamura, H., Hiramatsu, K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.29.3.1 · Cited by 407
Silencing of CXCR4 Blocks Breast Cancer Metastasis
Liang, Z., Yoon, Y., Votaw, J., Goodman, M. M., Williams, L., & Shim, H. (2005) · Cancer Research · doi:10.1158/0008-5472.967.65.3 · Cited by 402
Zagzag, D., Lukyanov, Y., Lan, L., Ali, M. A., Esencay, M., Mendez, O., Yee, H., Voura, E. B., & Newcomb, E. W. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700482 · Cited by 396
Sun, Y.-X., Schneider, A., Jung, Y., Wang, J., Dai, J., Wang, J., Cook, K., Osman, N. I., Koh-Paige, A. J., Shim, H., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041109 · Cited by 384
Self-citationRoots and stems: stem cells in cancer
Polyak, K., & Hahn, W. C. (2006) · Nature Medicine · doi:10.1038/nm1379 · Cited by 378
Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology
Ransohoff, R. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.010 · Cited by 371
CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival
Zhou, Y., Larsen, P. H., Hao, C., & Yong, V. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206222200 · Cited by 363
Marchesi, F., Monti, P., Leone, B. E., Zerbi, A., Vecchi, A., Piemonti, L., Mantovani, A., & Allavena, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1343 · Cited by 339
Epithelial cancer cell migration: a role for chemokine receptors?
Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., & Balkwill, F. R. (2001) · PubMed · Cited by 337
Phillips, R. J., Mestas, J., Gharaee-Kermani, M., Burdick, M. D., Sica, A., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500963200 · Cited by 323
Kijima, T., Maulik, G., Ma, P. C., Tibaldi, E. V., Turner, R. E., Rollins, B. J., Sattler, M., Johnson, B. E., & Salgia, R. (2002) · PubMed · Cited by 309
AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
Kalatskaya, I., Berchiche, Y. A., Gravel, S., Limberg, B. J., Rosenbaum, J. S., & Heveker, N. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053389 · Cited by 309
Libura, J., Drukala, J., Majka, M., Tomescu, O., Navenot, J. M., Kucia, M., Marquez, L., Peiper, S. C., Barr, F. G., Janowska-Wieczorek, A., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0031 · Cited by 306
Dambly-Chaudière, C., Cubedo, N., & Ghysen, A. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-23 · Cited by 297
Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing
Jung, Y., Wang, J., Schneider, A., Sun, Y.-X., Koh-Paige, A. J., Osman, N. I., McCauley, L. K., & Taichman, R. S. (2006) · Bone · doi:10.1016/j.bone.2005.10.003 · Cited by 290
Self-citationHartmann, T. N., Burger, J. A., Glodek, A., Fujii, N., & Burger, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208621 · Cited by 280
Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma
Scala, S., Ottaiano, A., Ascierto, P. A., Cavalli, M., Simeone, E., Giuliano, P., Napolitano, M., Franco, R., Botti, G., & Castello, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1887 · Cited by 280
Ao, M., Franco, O. E., Park, D., Raman, D., Williams, K., & Hayward, S. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3946 · Cited by 278
Burger, M., Glodek, A., Hartmann, T., Schmitt-Gräff, A., Silberstein, L. E., Fujii, N., Kipps, T. J., & Burger, J. A. (2003) · Oncogene · doi:10.1038/sj.onc.1207097 · Cited by 267
European Journal of Pharmacology
Engels, F. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.047 · Cited by 267
Mazzinghi, B., Ronconi, E., Lazzeri, E., Sagrinati, C., Ballerini, L., Angelotti, M. L., Parente, E., Mancina, R., Netti, G. S., Becherucci, F., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071903 · Cited by 264
CXC Chemokines in Cancer Angiogenesis and Metastases
(2010) · Advances in Cancer Research · doi:10.1016/s0065-230x(10)06003-3 · Cited by 263
Kim, S. Y., Lee, C. H., Midura, B. V., Yeung, C., Mendoza, A., Hong, S. H., Ren, L., Wong, D., Korz, W., Merzouk, A., et al. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9133-3 · Cited by 253
Sanz-Rodrı́guez, F., Hidalgo, A., & Teixidó, J. (2001) · Blood · doi:10.1182/blood.v97.2.346 · Cited by 249
Identification and expression of novel isoforms of human stromal cell-derived factor 1
Yu, L., Cecil, J., Peng, S.-B., Schrementi, J., Kovacevic, S., Paul, D., Su, E. W., & Wang, J. (2006) · Gene · doi:10.1016/j.gene.2006.02.001 · Cited by 232
Self-citationWRIGHT, L., MALONEY, W., YU, X., KINDLE, L., COLLINOSDOBY, P., & OSDOBY, P. (2005) · Bone · doi:10.1016/j.bone.2005.01.021 · Cited by 232
Hartmann, T. N., Grabovsky, V., Pasvolsky, R., Shulman, Z., Buss, E. C., Spiegel, A., Nagler, A., Lapidot, T., Thelen, M., & Alon, R. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208088 · Cited by 222
CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma.
Bertolini, F., Dell’Agnola, C., Mancuso, P., Rabascio, C., Burlini, A., Monestiroli, S., Gobbi, A., Pruneri, G., & Martinelli, G. (2002) · PubMed · Cited by 221
Activation of the hedgehog pathway in advanced prostate cancer.
Mori, T., Doi, R., Koizumi, M., et al. (2004) · PubMed · doi:10.1186/1476-4598-3-29 · Cited by 221
Kukreja, P., Abdel-Mageed, A. B., Mondal, D., Liu, K., & Agrawal, K. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1293 · Cited by 209
Jankowski, K., Kucia, M., Wysoczynski, M., Reca, R., Zhao, D., Trzyna, E., Trent, J. O., Peiper, S. C., Zembala, M., Ratajczak, J., et al. (2003) · PubMed · Cited by 206
Hojo, S., Koizumi, K., Tsuneyama, K., Arita, Y., Cui, Z., Shinohara, K., Minami, T., Hashimoto, I., Nakayama, T., Sakurai, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3424 · Cited by 201
Aiuti, A., Tavian, M., Cipponi, A., Ficara, F., Zappone, E., Hoxie, J., Peault, B., & Bordignon, C. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06<1823::aid-immu1823>3.0.co;2-b · Cited by 187
Functional diversity of SDF-1 splicing variants
Janowski, M. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.3.8260 · Cited by 184
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
Bieche, I., Chavey, C., Andrieu, C., Busson, M., Vacher, S., Le Corre, L., Guinebretiere, J.-M., Burlinchon, S., Lidereau, R., & Lazennec, G. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01301 · Cited by 183
CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 Integrins
Engl, T., Relja, B., Marian, D., Blumenberg, C., Müller, I., Beecken, W.-D., Jones, J., Ringel, E. M., Bereiter-Hahn, J., Jonas, D., et al. (2006) · Neoplasia · doi:10.1593/neo.05694 · Cited by 179
Kim, J., Mori, T., Chen, S. L., Amersi, F. F., Martinez, S. R., Kuo, C., Turner, R. R., Ye, X., Bilchik, A. J., Morton, D. L., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000217690.65909.9c · Cited by 175
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
Maréchal, R., Demetter, P., Nagy, N., Berton, A., Decaestecker, C., Polus, M., Closset, J., Devière, J., Salmon, I., & Van Laethem, J.-L. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605020 · Cited by 173
Feil, C., & Augustin, H. G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8499 · Cited by 172
Role of the intracellular domains of CXCR4 in SDF-1–mediated signaling
Roland, J., Murphy, B. J., Ahr, B., Robert-Hebmann, V., Delauzun, V., Nye, K. E., Devaux, C., & Biard-Piechaczyk, M. (2003) · Blood · doi:10.1182/blood-2002-03-0978 · Cited by 171
Sehgal, A., Keener, C. L., Boynton, A. L., Warrick, J., & Murphy, G. P. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199810)69:2<99::aid-jso10>3.0.co;2-m · Cited by 158
Cabıoğlu, N., Summy, J. M., Miller, C. P., Parikh, N. U., Şahin, A. A., Tuzlalı, S., Pumiglia, K. M., Gallick, G. E., & Price, J. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1303 · Cited by 157
Lazarini, F., Casanova, P., Tham, T. N., Clercq, E. D., Arenzana‐Seisdedos, F., Baleux, F., & Dubois-Dalcq, M. E. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00894.x · Cited by 155
Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone
Welch (2009) · Oncology Reports · doi:10.3892/or_00000282 · Cited by 152
Kyriakou, C. A., Rabin, N. K., Pizzey, A. R., Nathwani, A. C., & Yong, K. (2008) · Haematologica · doi:10.3324/haematol.12553 · Cited by 144
Lu, D., Tang, C., Yeh, W., Wong, K., Lin, C., Chen, Y., Lai, C., Chen, Y., Leung, Y., & Fu, W. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.001 · Cited by 137
Wegner, S. A., Ehrenberg, P. K., Chang, G. W., Dayhoff, D. E., Sleeker, A. L., & Michael, N. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4754 · Cited by 135
Emerging roles of chemokines in prostate cancer
Vindrieux, D., Escobar, P., & Lazennec, G. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0109 · Cited by 129
Begley, L., Monteleon, C. L., Shah, R. B., MacDonald, J. W., & Macoska, J. A. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00173.x · Cited by 128
Gao, Z., Wang, X., Wu, K., Zhao, Y., & Hu, G. (2010) · Pancreatology · doi:10.1159/000236012 · Cited by 126
Raggo, C. M., Ruhl, R. A., McAllister, S. C., Koon, H. B., Dezube, B. J., Früh, K., & Moses, A. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2822 · Cited by 126
Möhle, R., Moore, M. A. S., Nachman, R. L., & Rafii, S. (1997) · Blood · doi:10.1182/blood.v89.1.72 · Cited by 122
Genomic organization and promoter characterization of human CXCR4 gene1
Carúz, A., Samsom, M., Alonso, J. M., Alcamı́, J., Baleux, F., Virelizier, J. L., Parmentier, M., & Arenzana‐Seisdedos, F. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00359-7 · Cited by 116
The chemokine receptors CXCR4 and CXCR3 in cancer
Fulton, A. M. (2009) · Current Oncology Reports · doi:10.1007/s11912-009-0019-1 · Cited by 116
Grymuła, K., Tarnowski, M., Wysoczynski, M., Drukała, J., Barr, F. G., Ratajczak, J., Kucia, M., & Ratajczak, M. Z. (2010) · International Journal of Cancer · doi:10.1002/ijc.25245 · Cited by 112
Holland, J. D., Kochetkova, M., Akekawatchai, C., Dottore, M., Lopez, A. F., & McColl, S. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1631 · Cited by 112
Donahue, R. E., Jin, P., Bonifacino, A. C., Metzger, M. E., Ren, J., Wang, E., & Stroncek, D. F. (2009) · Blood · doi:10.1182/blood-2009-04-214403 · Cited by 111
Gupta, S. K., & Pillarisetti, K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2368 · Cited by 110
Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche
Gillette, J. M., Larochelle, A., Dunbar, C. E., & Lippincott‐Schwartz, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1838 · Cited by 108
Effects of CXCR4 antagonist CTCE‐9908 on prostate tumor growth
Porvasnik, S., Sakamoto, N., Kusmartsev, S. A., et al. (2009) · The Prostate · doi:10.1002/pros.21008 · Cited by 108
Imaging Ligand-Dependent Activation of CXCR7
Luker, K. E., Gupta, M., Steele, J. M., Foerster, B. R., & Luker, G. D. (2009) · Neoplasia · doi:10.1593/neo.09724 · Cited by 105
Kucia, M., Wojakowski, W., Reca, R., Machaliński, B., Goździk, J., Majka, M., Baran, J., Ratajczak, J., & Ratajczak, M. Z. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0015-1 · Cited by 104
Leukemia Inhibitory Factor: A Newly Identified Metastatic Factor in Rhabdomyosarcomas
Wysoczynski, M., Miękus, K., Jankowski, K., Wanzeck, J., Bertolone, S. J., Janowska‐Wieczorek, A., Ratajczak, J., & Ratajczak, M. Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1021 · Cited by 103
Iwakiri, S., Mino, N., Takahashi, T., Sonobe, M., Nagai, S., Okubo, K., Wada, H., Date, H., & Miyahara, R. (2009) · Cancer · doi:10.1002/cncr.24281 · Cited by 102
CXCL12, CXCR4 and CXCR7 expression in brain metastases
Salmaggi, A., Maderna, E., Calatozzolo, C., Gaviani, P., Canazza, A., Milanesi, I. M., Silvani, A., DiMeco, F., Carbone, A., & Pollo, B. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.17.9202 · Cited by 91
Martínez, A., Kapas, S., Miller, M.-J., Ward, Y., & Cuttitta, F. F. (2000) · Endocrinology · doi:10.1210/endo.141.1.7261 · Cited by 91
Complete nucleotide sequence of a putative G protein coupled receptor: RDC1
Liert, F., Parmentier, M., Lefort, A., Dumont, J. E., & Vassart, G. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.7.1917 · Cited by 90
Tissue Microenvironment Modulates CXCR4 Expression and Tumor Metastasis in Neuroblastoma
Zhang, L., Yeger, H., Das, B., Irwin, M. S., & Baruchel, S. (2007) · Neoplasia · doi:10.1593/neo.06670 · Cited by 81
Tumor‐promoting phenotype of CD90hi prostate cancer‐associated fibroblasts
Zhao, H., & Peehl, D. M. (2009) · The Prostate · doi:10.1002/pros.20946 · Cited by 78
Tarnowski, M., Grymuła, K., Reca, R., Jankowski, K., Maksym, R., Tarnowska, J., Przybylski, G. K., Barr, F. G., Kucia, M., & Ratajczak, M. Z. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0259 · Cited by 78
Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma
Razmkhah, M., Talei, A., Doroudchi, M., Khalili-Azad, T., & Ghaderi, A. A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.039 · Cited by 77
Ratajczak, M. Z., Reca, R., Wysoczynski, M., Yan, J., & Ratajczak, J. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.03.015 · Cited by 75
Princen, K., Hatse, S., Vermeire, K., Clercq, E. D., & Schols, D. (2002) · Cytometry Part A · doi:10.1002/cyto.a.10008 · Cited by 74
Ueda, Y., Neel, N., Schutyser, E., Raman, D., & Richmond, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3579 · Cited by 63
Role of Chemokines and Their Receptors in Cancer
Kruizinga, R. C., Bestebroer, J., Berghuis, P., de Haas, C. J. C., Links, T. P., de Vries, E. G. E., & Walenkamp, A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789105081 · Cited by 60
Differential Expression of RDC1/CXCR7 in the Human Placenta
Tripathi, V., Verma, R., Dinda, A. K., Malhotra, N., Kaur, J., & Luthra, K. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9258-4 · Cited by 50
CXCR4/CCR5 Down-modulation and Chemotaxis Are Regulated by the Proteasome Pathway
Fernandis, A. Z., Cherla, R. P., Chernock, R. D., & Ganju, R. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200750200 · Cited by 48
CXCL12 Activates a Robust Transcriptional Response in Human Prostate Epithelial Cells
Begley, L., MacDonald, J. W., Day, M. L., & Macoska, J. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700440200 · Cited by 48
Jones, S. W., Brockbank, S., Mobbs, M., Good, N. L., Soma-Haddrick, S., Heuze, A. J., Langham, C., Timms, D. A., Newham, P., & Needham, M. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.01.007 · Cited by 46
Wysoczynski, M., Kucia, M., Ratajczak, J., & Ratajczak, M. Z. (2007) · Leukemia · doi:10.1038/sj.leu.2404629 · Cited by 41
Lee, R. L., Westendorf, J., & Gold, M. R. (2007) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-007-0006-y · Cited by 41
Dettin, M., Pasquato, A., Scarinci, C., Zanchetta, M., Rossi, A. D., & Bello, C. D. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031067a · Cited by 19
Cited by
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.49 · Cited by 2,206
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
The Intricate Role of CXCR4 in Cancer
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-411638-2.00002-1 · Cited by 672
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
Mollica Poeta, V., Massara, M., Capucetti, A., & Bonecchi, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00379 · Cited by 583
CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
Duda, D. G., Kozin, S. V., Kirkpatrick, N. D., Xu, L., Fukumura, D., & Jain, R. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2636 · Cited by 395
Metadata
- Authors
- Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Zhang, J., Taichman, R. S., Pienta, K. J., & Wang, J.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2010-09-14
- Volume
- 29
- Issue
- 4
- Pages
- 709-722
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2121548063
- Cited by
- 727
- References
- 130
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.